Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence

Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence

Compositions and methods for modulating human immunodeficiency virus (HIV) infection involving substances that inhibit the ability of high mobility box 1 (HMGB1) protein to interact with natural killer (NK) cells. Therapeutic compositions comprising antibodies and drugs, such as glycyrrhizin, which...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MELKI MARIE-THERESE, SEFFER VALERIE, SAIDI HELA, GOUGEON MARIE-LISE, POIRIER-BEAUDOIN BEATRICE
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MELKI MARIE-THERESE
SEFFER VALERIE
SAIDI HELA
GOUGEON MARIE-LISE
POIRIER-BEAUDOIN BEATRICE
description Compositions and methods for modulating human immunodeficiency virus (HIV) infection involving substances that inhibit the ability of high mobility box 1 (HMGB1) protein to interact with natural killer (NK) cells. Therapeutic compositions comprising antibodies and drugs, such as glycyrrhizin, which bind to HMGB1. Methods of detecting or monitoring HIV infection involving detection or quantitation of HMGB1 or antibodies specific for HMGB1 in a biological sample.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9164103B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9164103B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9164103B23</originalsourceid><addsrcrecordid>eNqNjU0OgjAQhdm4MOod5gIkIsbELUbFBSt_tqS0U5gEpk1bTLiEZxaIB3D18pL3fW8ZfQrDFIwjrkGwAuKGKgpTbfpOMFDX9WwUapKELAd4k-v9uNMoAxmGaoDOqL4VM5QX1ywBhRZZIQcIjuoaZ73RkN9ecQIObUtSzPT0adF58mG04zpaaNF63PxyFcHl_DjlMVpTordCImMon_djctgn2zTbpX9MvnFzTkE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence</title><source>esp@cenet</source><creator>MELKI MARIE-THERESE ; SEFFER VALERIE ; SAIDI HELA ; GOUGEON MARIE-LISE ; POIRIER-BEAUDOIN BEATRICE</creator><creatorcontrib>MELKI MARIE-THERESE ; SEFFER VALERIE ; SAIDI HELA ; GOUGEON MARIE-LISE ; POIRIER-BEAUDOIN BEATRICE</creatorcontrib><description>Compositions and methods for modulating human immunodeficiency virus (HIV) infection involving substances that inhibit the ability of high mobility box 1 (HMGB1) protein to interact with natural killer (NK) cells. Therapeutic compositions comprising antibodies and drugs, such as glycyrrhizin, which bind to HMGB1. Methods of detecting or monitoring HIV infection involving detection or quantitation of HMGB1 or antibodies specific for HMGB1 in a biological sample.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; TESTING</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151020&amp;DB=EPODOC&amp;CC=US&amp;NR=9164103B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151020&amp;DB=EPODOC&amp;CC=US&amp;NR=9164103B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MELKI MARIE-THERESE</creatorcontrib><creatorcontrib>SEFFER VALERIE</creatorcontrib><creatorcontrib>SAIDI HELA</creatorcontrib><creatorcontrib>GOUGEON MARIE-LISE</creatorcontrib><creatorcontrib>POIRIER-BEAUDOIN BEATRICE</creatorcontrib><title>Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence</title><description>Compositions and methods for modulating human immunodeficiency virus (HIV) infection involving substances that inhibit the ability of high mobility box 1 (HMGB1) protein to interact with natural killer (NK) cells. Therapeutic compositions comprising antibodies and drugs, such as glycyrrhizin, which bind to HMGB1. Methods of detecting or monitoring HIV infection involving detection or quantitation of HMGB1 or antibodies specific for HMGB1 in a biological sample.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjU0OgjAQhdm4MOod5gIkIsbELUbFBSt_tqS0U5gEpk1bTLiEZxaIB3D18pL3fW8ZfQrDFIwjrkGwAuKGKgpTbfpOMFDX9WwUapKELAd4k-v9uNMoAxmGaoDOqL4VM5QX1ywBhRZZIQcIjuoaZ73RkN9ecQIObUtSzPT0adF58mG04zpaaNF63PxyFcHl_DjlMVpTordCImMon_djctgn2zTbpX9MvnFzTkE</recordid><startdate>20151020</startdate><enddate>20151020</enddate><creator>MELKI MARIE-THERESE</creator><creator>SEFFER VALERIE</creator><creator>SAIDI HELA</creator><creator>GOUGEON MARIE-LISE</creator><creator>POIRIER-BEAUDOIN BEATRICE</creator><scope>EVB</scope></search><sort><creationdate>20151020</creationdate><title>Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence</title><author>MELKI MARIE-THERESE ; SEFFER VALERIE ; SAIDI HELA ; GOUGEON MARIE-LISE ; POIRIER-BEAUDOIN BEATRICE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9164103B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>MELKI MARIE-THERESE</creatorcontrib><creatorcontrib>SEFFER VALERIE</creatorcontrib><creatorcontrib>SAIDI HELA</creatorcontrib><creatorcontrib>GOUGEON MARIE-LISE</creatorcontrib><creatorcontrib>POIRIER-BEAUDOIN BEATRICE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MELKI MARIE-THERESE</au><au>SEFFER VALERIE</au><au>SAIDI HELA</au><au>GOUGEON MARIE-LISE</au><au>POIRIER-BEAUDOIN BEATRICE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence</title><date>2015-10-20</date><risdate>2015</risdate><abstract>Compositions and methods for modulating human immunodeficiency virus (HIV) infection involving substances that inhibit the ability of high mobility box 1 (HMGB1) protein to interact with natural killer (NK) cells. Therapeutic compositions comprising antibodies and drugs, such as glycyrrhizin, which bind to HMGB1. Methods of detecting or monitoring HIV infection involving detection or quantitation of HMGB1 or antibodies specific for HMGB1 in a biological sample.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9164103B2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
title Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A02%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MELKI%20MARIE-THERESE&rft.date=2015-10-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9164103B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true